๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The measurement of the psychotropic effects of an androgen in aging males with psychovegetative symptomatology: A controlled double blind study mesterolone versus placebo

โœ Scribed by Kaiser, E.; Kies, N.; Maass, G.; Schmidt, H.; Beach, R.C.; Bormacher, K.; Herrmann, W.M.; Richter, E.

Book ID
122822420
Publisher
Elsevier Science
Year
1978
Weight
742 KB
Volume
2
Category
Article
ISSN
0364-7722

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A double-blind, placebo-controlled study
A double-blind, placebo-controlled study of the effects of eptastigmine on scopolamine-induced cognitive deficits in healthy male subjects
โœ C. R. Lines; J. H. Ambrose; A. Heald; M. Traub ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 612 KB

This double-blind, placebo-controlled, crossover study examined the effects of two single doses of eptastigmine, a novel cholinesterase inhibitor, on scopolamine-induced cognitive deficits in 24 healthy male volunteers. Each subject received the following treatment sequences, separated by at least 1

The antiosteoporotic efficacy of intrave
The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade : A double blind, randomized, placebo-controlled crossover study
โœ Terrence H. Diamond; Julie Winters; Angie Smith; Paul De Souza; John H. Kersley; ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 96 KB ๐Ÿ‘ 2 views

## BACKGROUND. Prostate carcinoma therapy with combined androgen blockade may result in high bone-turnover with significant bone loss. This study was undertaken to evaluate the antiosteoporotic efficacy of intravenous pamidronate in a double blind, randomized, placebo-controlled, crossover study.